Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?

Bijan J. Borah; Naveen Pereira; Michael E. Farkouh

doi:10.1007/s10557-017-6720-7

Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?

Bijan J. Borah, Naveen Pereira, Michael E. Farkouh

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Journal	Cardiovascular Drugs and Therapy
Volume	31
Issue number	1
DOIs	https://doi.org/10.1007/s10557-017-6720-7
State	Published - Feb 1 2017

ASJC Scopus subject areas

Pharmacology
Cardiology and Cardiovascular Medicine
Pharmacology (medical)

Access to Document

10.1007/s10557-017-6720-7

Cite this

@article{f85d1d250b9d48baa2a779f7672e479a,

title = "Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?",

author = "Borah, {Bijan J.} and Naveen Pereira and Farkouh, {Michael E.}",

year = "2017",

month = feb,

day = "1",

doi = "10.1007/s10557-017-6720-7",

language = "English (US)",

volume = "31",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Kluwer Academic Publishers",

number = "1",

}

TY - JOUR

T1 - Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI)

T2 - Are They Cost-effective?

AU - Borah, Bijan J.

AU - Pereira, Naveen

AU - Farkouh, Michael E.

PY - 2017/2/1

Y1 - 2017/2/1

UR - http://www.scopus.com/inward/record.url?scp=85014105661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014105661&partnerID=8YFLogxK

U2 - 10.1007/s10557-017-6720-7

DO - 10.1007/s10557-017-6720-7

M3 - Editorial

C2 - 28251381

AN - SCOPUS:85014105661

SN - 0920-3206

VL - 31

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

IS - 1

ER -

Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this